APAC Medical Foods for Inborn Errors of Metabolism Market - Industry Trends and Forecast to 2030

TABLE OF CONTENTS

1 INTRODUCTION 59

• 1.1 OBJECTIVES OF THE STUDY 59
• 1.2 MARKET DEFINITION 59
• 1.3 OVERVIEW 59
• 1.4 CURRENCY AND PRICING 61
• 1.5 LIMITATIONS 61
• 1.6 MARKETS COVERED 61

2 MARKET SEGMENTATION 67

• 2.1 MARKETS COVERED 67
• 2.2 GEOGRAPHICAL SCOPE 68
• 2.3 YEARS CONSIDERED FOR THE STUDY 69
• 2.4 DBMR TRIPOD DATA VALIDATION MODEL 70
• 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 73
• 2.6 MULTIVARIATE MODELLING 74
• 2.7 PRODUCTS LIFELINE CURVE 74
• 2.8 DBMR MARKET POSITION GRID 75
• 2.9 SECONDARY SOURCES 77
• 2.10 ASSUMPTIONS 77

3 EXECUTIVE SUMMARY 78

4 PREMIUM INSIGHT 81

• 4.1 PESTEL ANALYSIS 82
• 4.2 PORTER'S FIVE FORCES MODEL 83
• 4.3 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET ANALYSIS 84
• 4.4 PATENT ANALYSIS 85

5 PIPELINE ANALYSIS 87

6 EPIDEMIOLOGY 88

7 INDUSTRY INSIGHTS 89

• 7.1 DEMOGRAPHIC TRENDS 89
• 7.2 KEY PRICING STRATEGIES 91
• 7.3 KEY PATIENT ENROLLMENT STRATEGIES 92

8 REGULATORY SCENARIO FOR MEDICAL FOOD 94

9 MARKET OVERVIEW 97

• 9.1 DRIVERS 99
  • 9.1.1 RISING INCIDENCES OF INBORN ERRORS OF METABOLISM (IEM) 99
  • 9.1.2 RISING PREFERENCE FOR DIETARY SUPPLEMENTS OVER ENZYME REPLACEMENT THERAPY (ERT) 100
  • 9.1.3 INCREASE IN THE NUMBER OF NEW-BORN SCREENING PROCEDURES 101
  • 9.1.4 INCREASING SPENDING ON MEDICAL FOOD PRODUCTS 102
• 9.2 RESTRAINTS 103
  • 9.2.1 HIGH COST OF MEDICAL FOODS 103
  • 9.2.2 STRINGENT REGULATIONS FOR MEDICAL FOODS 104
• 9.3 OPPORTUNITIES 105
  • 9.3.1 GOVERNMENT INITIATIVES AND PROGRAMS FOR CREATING AWARENESS ABOUT INBORN ERRORS OF METABOLISM 105
  • 9.3.2 INCREASING COLLABORATIONS AND PARTNERSHIPS IN THE MARKET 107
  • 9.3.3 EXPANSION OF MEDICAL FOODS IN EMERGING MARKETS 107
• 9.4 CHALLENGES 108
  • 9.4.1 POOR ACCESSIBILITY OF MEDICAL FOODS 108
  • 9.4.2 ALTERNATIVE TREATMENT APPROACHES FOR INBORN ERRORS OF METABOLISM 109

10 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS 110

• 10.1 OVERVIEW 111
• 10.2 AMINO ACID 114
  • 10.2.1 AMINO ACID MIXTURES 115
    • 10.2.1.1 PHENYLADE 116
      • 10.2.1.1.1 DRINK MIX 116
      • 10.2.1.1.2 GMP MIX-IN 116
      • 10.2.1.1.3 GMP READY 116
      • 10.2.1.1.4 OTHERS 116
    • 10.2.1.2 PERIFLEX 116
    • 10.2.1.3 LOPHLEX 117
    • 10.2.1.4 PHLEXY 117
    • 10.2.1.5 COOLER 117
    • 10.2.1.6 ANAMIX 117
    • 10.2.1.7 LYSINE-FREE, LOW TRYPTOPHAN 117
    • 10.2.1.8 GLUTARADE ESSENTIAL GA-1 117
    • 10.2.1.9 GLUTARADE GA-1 AMINO ACID BLEND 117
    • 10.2.1.10 GLYTACTIN WITH GMP 117
    • 10.2.1.11 ESSENTIAL AMINO ACID MIX 117
    • 10.2.1.12 LIQUIGEN 117
    • 10.2.1.13 MSUD GEL 118
    • 10.2.1.14 OTHERS 118
  • 10.2.2 SINGLE AMINO ACID 118
    • 10.2.2.1 L-ARGININE 118
    • 10.2.2.2 L-ISOLEUCINE 118
    • 10.2.2.3 L-TYROSINE 119
    • 10.2.2.4 L-LEUCINE 119
    • 10.2.2.5 GLYCINE 119
    • 10.2.2.6 L-ASPARTIC ACID 119
    • 10.2.2.7 L-CITRULLINE 119
    • 10.2.2.8 OTHERS 119
• 10.3 LOW PROTEIN FOOD 119
  • 10.3.1 LOW-PROTEIN BAKING MIXES AND FLOUR SUBSTITUTES, SUCH AS RICE FLOUR OR POTATO FLOUR 121
  • 10.3.2 LOW-PROTEIN ENERGY BARS AND SNACKS 121
  • 10.3.3 LOW-PROTEIN CEREALS AND BREAKFAST FOOD 121
  • 10.3.4 LOW-PROTEIN MILK SUBSTITUTES, SUCH AS RICE MILK OR ALMOND MILK 121
  • 10.3.5 LOW-PROTEIN BREAD, PASTA, AND OTHER GRAIN-BASED PRODUCTS 121
  • 10.3.6 OTHERS 121
• 10.4 GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON 121
  • 10.4.1 BY FLAVOUR 122
    • 10.4.1.1 VANILLA 122
    • 10.4.1.2 BERRY 122
    • 10.4.1.3 ORANGE 123
    • 10.4.1.4 PLAIN 123
    • 10.4.1.5 OTHERS 123
  • 10.4.2 BY USAGE 123
    • 10.4.2.1 READY TO DRINK 123
    • 10.4.2.2 NEED DILUTION/PREPARATION 123
• 10.5 LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON 124
  • 10.5.1 NO CALCIUM OR VITAMIN D 125
  • 10.5.2 LOW CALCIUM, NO VITAMIN D 125
  • 10.5.3 OTHERS 125
• 10.6 OTHERS 125

11 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES 127

• 11.1 OVERVIEW 128
• 11.2 PHENYLKETONURIA (PKU) 131
  • 11.2.1 PHENYLADE 132
  • 11.2.2 PERIFLEX 132
  • 11.2.3 LOPHLEX 132
  • 11.2.4 OTHERS 132
• 11.3 TYROSINEMIA TYPES I AND II 132
• 11.4 MAPLE SYRUP URINE DISEASE (MSUD) 133
  • 11.4.1 ANAMIX 134
  • 11.4.2 COOLER 134
  • 11.4.3 MSUD GEL 134
  • 11.4.4 AMINO ACID BLEND 134
  • 11.4.5 MAXMUM 134
  • 11.4.6 OTHERS 134
• 11.5 HOMOCYSTINURIA 135
• 11.6 GLUTARIC ACIDEMIA TYPE I 135
• 11.7 UREA CYCLE DISORDERS 136
  • 11.7.1 ORNITHINE TRANSCARBAMYLASE DEFICIENCY (OTC) 137
  • 11.7.2 CARBAMYL PHOSPHATE SYNTHETASE DEFICIENCY (CPS) 137
  • 11.7.3 CITRULLINAEMIA 137
  • 11.7.4 N-ACETYLGLUTAMATE SYNTHETASE DEFICIENCY (NAGS) 137
  • 11.7.5 ARGINASE DEFICIENCY (AG) 138
  • 11.7.6 ARGININOSUCCINIC ACIDURIA (ASA) 138
  • 11.7.7 OTHERS 138
• 11.8 METHYLMALONIC ACIDEMIA 138
• 11.9 ISOVALERIC ACIDEMIA 139
• 11.10 ORGANIC ACIDURIAS 140
• 11.11 RENAL DISEASE 140
• 11.12 PROPIONIC ACIDEMIA 141
• 11.13 DISORDERS OF LEUCINE METABOLISM 142
• 11.14 OTHERS 143

12 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP 144

• 12.1 OVERVIEW 145
• 12.2 INFANTS 148
• 12.3 WEANING 148
• 12.4 ADOLESCENT 149
• 12.5 ADULTS 150

13 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS 151

• 13.1 OVERVIEW 152
• 13.2 POWDER 155
• 13.3 LIQUID 155
• 13.4 TABLETS 156
• 13.5 GELS 157
• 13.6 OTHERS 158

14 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING 159

• 14.1 OVERVIEW 160
• 14.2 CAN 163
• 14.3 PACKETS 163
• 14.4 BOTTLE 164
• 14.5 JAR 165
• 14.6 OTHERS 165

15 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL 167

• 15.1 OVERVIEW 168
• 15.2 HOSPITAL PHARMACY 171
• 15.3 RETAIL PHARMACY 171
• 15.4 DRUG STORES 172
• 15.5 ONLINE PHARMACY 173
• 15.6 OTHERS 173

16 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION 175

• 16.1 ASIA-PACIFIC 176
  • 16.1.1 CHINA 191
  • 16.1.2 JAPAN 201
  • 16.1.3 INDIA 210
  • 16.1.4 AUSTRALIA 220
  • 16.1.5 SOUTH KOREA 230
  • 16.1.6 THAILAND 239
  • 16.1.7 SINGAPORE 249
  • 16.1.8 INDONESIA 258
  • 16.1.9 MALAYSIA 267
  • 16.1.10 NEW ZEALAND 276
  • 16.1.11 VIETNAM 284
  • 16.1.12 PHILIPPINES 292
  • 16.1.13 TAIWAN 302
  • 16.1.14 REST OF ASIA-PACIFIC 311

17 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, COMPANY LANDSCAPE 312

• 17.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 312

18 SWOT ANALYSIS 313

19 COMPANY PROFILE 314

• 19.1 ABBOTT 314
  • 19.1.1 COMPANY SNAPSHOT 314
  • 19.1.2 REVENUE ANALYSIS 314
  • 19.1.3 COMPANY SHARE ANALYSIS 315
  • 19.1.4 PRODUCT PORTFOLIO 315
  • 19.1.5 RECENT DEVELOPMENT 316
• 19.2 NESTLE HEALTH SCIENCE (A SUBSIDIARY OF NESTLE) 317
  • 19.2.1 COMPANY SNAPSHOT 317
  • 19.2.2 COMPANY SHARE ANALYSIS 317
  • 19.2.3 PRODUCT PORTFOLIO 318
  • 19.2.4 RECENT DEVELOPMENT 318
• 19.3 AJINOMOTO CAMBROOKE, INC. (A SUBSIDIARY OF AJINOMOTO CO., INC.) 319
  • 19.3.1 COMPANY SNAPSHOT 319
  • 19.3.2 COMPANY SHARE ANALYSIS 319
  • 19.3.3 PRODUCT PORTFOLIO 320
  • 19.3.4 RECENT DEVELOPMENTS 320
• 19.4 MEAD JOHNSON & COMPANY, LLC. (A SUBSIDIARY OF RECKITT BENCKISER GROUP PLC.) 321
  • 19.4.1 COMPANY SNAPSHOT 321
  • 19.4.2 COMPANY SHARE ANALYSIS 321
  • 19.4.3 PRODUCT PORTFOLIO 322
  • 19.4.4 RECENT DEVELOPMENT 322
• 19.5 NUTRICIA (A SUBSIDIARY OF DANONE) 323
  • 19.5.1 COMPANY SNAPSHOT 323
  • 19.5.2 COMPANY SHARE ANALYSIS 323
  • 19.5.3 PRODUCT PORTFOLIO 324
  • 19.5.4 RECENT DEVELOPMENT 325
• 19.6 APR 326
  • 19.6.1 COMPANY SNAPSHOT 326
  • 19.6.2 PRODUCT PORTFOLIO 326
  • 19.6.3 RECENT DEVELOPMENT 326
• 19.7 B.BRAUN SE 327
  • 19.7.1 COMPANY SNAPSHOT 327
  • 19.7.2 PRODUCT PORTFOLIO 327
  • 19.7.3 RECENT DEVELOPMENT 327
• 19.8 BAXTER 328
  • 19.8.1 COMPANY SNAPSHOT 328
  • 19.8.2 REVENUE ANALYSIS 328
  • 19.8.3 PRODUCT PORTFOLIO 329
  • 19.8.4 RECENT DEVELOPMENT 329
• 19.9 DR. SCHAR AG / SPA 330
  • 19.9.1 COMPANY SNAPSHOT 330
  • 19.9.2 PRODUCT PORTFOLIO 330
  • 19.9.3 RECENT DEVELOPMENT 331
• 19.10 EBM MEDICAL 332
  • 19.10.1 COMPANY SNAPSHOT 332
  • 19.10.2 PRODUCT PORTFOLIO 332
  • 19.10.3 RECENT DEVELOPMENT 332
• 19.11 ENER-G FOODS, INC. 333
  • 19.11.1 COMPANY SNAPSHOT 333
  • 19.11.2 PRODUCT PORTFOLIO 333
  • 19.11.3 RECENT DEVELOPMENT 333
• 19.12 FRESENIUS KABI AG (SUBSIDIARY OF FRESENIUS SE & CO. KGAA) 334
  • 19.12.1 COMPANY SNAPSHOT 334
  • 19.12.2 PRODUCT PORTFOLIO 334
  • 19.12.3 RECENT DEVELOPMENT 334
• 19.13 GALEN LIMITED 335
  • 19.13.1 COMPANY SNAPSHOT 335
  • 19.13.2 PRODUCT PORTFOLIO 335
  • 19.13.3 RECENT DEVELOPMENTS 335
• 19.14 HEXAGONNUTRITION LTD. 336
  • 19.14.1 COMPANY SNAPSHOT 336
  • 19.14.2 PRODUCT PORTFOLIO 336
  • 19.14.3 RECENT DEVELOPMENT 336
• 19.15 KATE FARMS 337
  • 19.15.1 COMPANY SNAPSHOT 337
  • 19.15.2 PRODUCT PORTFOLIO 337
  • 19.15.3 RECENT DEVELOPMENTS 338
• 19.16 MEIJI HOLDINGS CO., LTD. 339
  • 19.16.1 COMPANY SNAPSHOT 339
  • 19.16.2 REVENUE ANALYSIS 339
  • 19.16.3 PRODUCT PORTFOLIO 340
  • 19.16.4 RECENT DEVELOPMENT 340

• 19.17 ORPHARMA PTY LTD. 341
  • 19.17.1 COMPANY SNAPSHOT 341
  • 19.17.2 PRODUCT PORTFOLIO 341
  • 19.17.3 RECENT DEVELOPMENT 341
• 19.18 PIAM FARMACEUTICI S.P.A 342
  • 19.18.1 COMPANY SNAPSHOT 342
  • 19.18.2 PRODUCT PORTFOLIO 343
  • 19.18.3 RECENT DEVELOPMENT 343
• 19.19 PKU PERSPECTIVES 344
  • 19.19.1 COMPANY SNAPSHOT 344
  • 19.19.2 PRODUCT PORTFOLIO 344
  • 19.19.3 RECENT DEVELOPMENTS 344
• 19.20 PKU-MDMIL 345
  • 19.20.1 COMPANY SNAPSHOT 345
  • 19.20.2 PRODUCT PORTFOLIO 345
  • 19.20.3 RECENT DEVELOPMENT 345
• 19.21 PRIMUS PHARMACEUTICALS, INC. 346
  • 19.21.1 COMPANY SNAPSHOT 346
  • 19.21.2 PRODUCT PORTFOLIO 346
  • 19.21.3 RECENT DEVELOPMENT 346
• 19.22 PRISTINE ORGANICS PRIVATE LIMITED 347
  • 19.22.1 COMPANY SNAPSHOT 347
  • 19.22.2 PRODUCT PORTFOLIO 348
  • 19.22.3 RECENT DEVELOPMENT 348
• 19.23 PROMIN METABOLICS 349
  • 19.23.1 COMPANY SNAPSHOT 349
  • 19.23.2 PRODUCT PORTFOLIO 350
  • 19.23.3 RECENT DEVELOPMENT 350
• 19.24 SOLACE NUTRITION 351
  • 19.24.1 COMPANY SNAPSHOT 351
  • 19.24.2 PRODUCT PORTFOLIO 351
  • 19.24.3 RECENT DEVELOPMENT 352

20 QUESTIONNAIRE 353

21 RELATED REPORTS 357

LIST OF TABLES

• TABLE 1 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, PATENT ANALYSIS 57
• TABLE 2 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, PIPELINE ANALYSIS 59
• TABLE 3 COSTS OF MEDICAL FOODS USED IN INBORN ERRORS OF METABOLISM (IEMS) 63
• TABLE 4 THE MANUFACTURING OF MEDICAL FOOD MUST COMPLY WITH THE BELOW GIVEN FDA REQUIREMENT: 66
• TABLE 5 COSTS OF MEDICAL FOODS 75
• TABLE 6 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-20307 (USD MILLION) 85
• TABLE 7 ASIA PACIFIC AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 86
• TABLE 8 ASIA PACIFIC AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 86
• TABLE 9 ASIA PACIFIC AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 87
• TABLE 10 ASIA PACIFIC PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 88
• TABLE 11 ASIA PACIFIC SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 90
• TABLE 12 ASIA PACIFIC LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2030 (USD MILLION) 92
• TABLE 13 ASIA PACIFIC LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 92
• TABLE 14 ASIA PACIFIC GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 94
• TABLE 15 ASIA PACIFIC GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVOURS, 2021-2030 (USD MILLION) 94
• TABLE 16 ASIA PACIFIC GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGE, 2021-2030 (USD MILLION) 95
• TABLE 17 ASIA PACIFIC LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 96
• TABLE 18 ASIA PACIFIC LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 96
• TABLE 19 ASIA PACIFIC OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 98
• TABLE 20 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION) 102
• TABLE 21 ASIA PACIFIC PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 103
• TABLE 22 ASIA PACIFIC PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION) 103
• TABLE 23 ASIA PACIFIC TYROSINEMIA TYPES I AND II IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 105
• TABLE 24 ASIA PACIFIC MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 105
• TABLE 25 ASIA PACIFIC MAPLE SYRUP URINE DISEASE(MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2030 (USD MILLION) 106
• TABLE 26 ASIA PACIFIC HOMOCYSTINURIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 107
• TABLE 27 ASIA PACIFIC GLUTARIC ACIDEMIA TYPE I IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 108
• TABLE 28 ASIA PACIFIC UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 108
• TABLE 29 ASIA PACIFIC UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION) 109
• TABLE 30 ASIA PACIFIC METHYLMALONIC ACIDEMIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 110
• TABLE 31 ASIA PACIFIC ISOVALERIC ACIDEMIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 111
• TABLE 32 ASIA PACIFIC ORGANIC ACIDURIAS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 112
• TABLE 33 ASIA PACIFIC RENAL DISEASE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2030 (USD MILLION) 113
• TABLE 34 ASIA PACIFIC PROPIONIC ACIDEMIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 113
• TABLE 35 ASIA PACIFIC DISORDERS OF LEUCINE METABOLISM IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 114
• TABLE 36 ASIA PACIFIC OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 115
• TABLE 37 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 119
• TABLE 38 ASIA PACIFIC INFANTS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 120
• TABLE 39 ASIA PACIFIC WEANING IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 121
• TABLE 40 ASIA PACIFIC ADOLESCENT IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 121
• TABLE 41 ASIA PACIFIC ADULTS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 122
• TABLE 42 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION) 126
• TABLE 43 ASIA PACIFIC POWDER IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 127
• TABLE 44 ASIA PACIFIC LIQUID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 128
• TABLE 45 ASIA PACIFIC TABLETS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 128
• TABLE 46 ASIA PACIFIC GELS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 129
• TABLE 47 ASIA PACIFIC OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 130
• TABLE 48 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION) 134
• TABLE 49 ASIA PACIFIC CAN IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 135
• TABLE 50 ASIA PACIFIC PACKETS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 136
• TABLE 51 ASIA PACIFIC BOTTLE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 136
• TABLE 52 ASIA PACIFIC JAR IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 137
• TABLE 53 ASIA PACIFIC OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 138
• TABLE 54 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 142
• TABLE 55 ASIA PACIFIC HOSPITAL PHARMACY IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 143
• TABLE 56 ASIA PACIFIC RETAIL PHARMACY IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 144
• TABLE 57 ASIA PACIFIC DRUG STORES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 144
• TABLE 58 ASIA PACIFIC ONLINE PHARMACY IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 145
• TABLE 59 ASIA PACIFIC OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2021-2030 (USD MILLION) 146
• TABLE 60 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 152
• TABLE 61 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 153
• TABLE 62 ASIA-PACIFIC AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 153
• TABLE 63 ASIA-PACIFIC AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 154
• TABLE 64 ASIA-PACIFIC PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 155
• TABLE 65 ASIA-PACIFIC SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 155
• TABLE 66 ASIA-PACIFIC LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 156
• TABLE 67 ASIA-PACIFIC GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION) 156
• TABLE 68 ASIA-PACIFIC GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION) 157
• TABLE 69 ASIA-PACIFIC LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 157
• TABLE 70 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION) 158
• TABLE 71 ASIA-PACIFIC PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION) 159
• TABLE 72 ASIA-PACIFIC MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION) 159
• TABLE 73 ASIA-PACIFIC UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION) 160
• TABLE 74 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 160
• TABLE 75 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION) 161
• TABLE 76 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION) 161
• TABLE 77 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 162
• TABLE 78 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 163
• TABLE 79 CHINA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 163
• TABLE 80 CHINA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 164
• TABLE 81 CHINA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 165
• TABLE 82 CHINA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 165
• TABLE 83 CHINA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 166
• TABLE 84 CHINA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION) 166
• TABLE 85 CHINA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION) 167
• TABLE 86 CHINA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 167
• TABLE 87 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION) 168
• TABLE 88 CHINA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION) 169
• TABLE 89 CHINA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION) 169
• TABLE 90 CHINA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION) 170
• TABLE 91 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 170
• TABLE 92 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION) 171
• TABLE 93 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION) 171
• TABLE 94 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 172
• TABLE 95 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 173
• TABLE 96 JAPAN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 173
• TABLE 97 JAPAN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 174
• TABLE 98 JAPAN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 175
• TABLE 99 JAPAN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 175
• TABLE 100 JAPAN LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 176
• TABLE 101 JAPAN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION) 176
• TABLE 102 JAPAN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION) 177
• TABLE 103 JAPAN LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 177
• TABLE 104 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION) 178
• TABLE 105 JAPAN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION) 178
• TABLE 106 JAPAN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION) 179
• TABLE 107 JAPAN UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION) 179
• TABLE 108 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 180
• TABLE 109 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION) 180
• TABLE 110 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION) 181
• TABLE 111 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 181
• TABLE 112 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 182
• TABLE 113 INDIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 182
• TABLE 114 INDIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 183
• TABLE 115 INDIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 184
• TABLE 116 INDIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 184
• TABLE 117 INDIA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 185
• TABLE 118 INDIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2021-2030 (USD MILLION) 185
• TABLE 119 INDIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2021-2030 (USD MILLION) 186
• TABLE 120 INDIA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 186
• TABLE 121 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION) 187
• TABLE 122 INDIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION) 188
• TABLE 123 INDIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION) 188
• TABLE 124 INDIA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2021-2030 (USD MILLION) 189
• TABLE 125 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 189
• TABLE 126 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2021-2030 (USD MILLION) 190
• TABLE 127 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2021-2030 (USD MILLION) 190
• TABLE 128 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 191
• TABLE 129 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 192
• TABLE 130 AUSTRALIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2021-2030 (USD MILLION) 192

LIST OF FIGURES

• FIGURE 1 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: SEGMENTATION 38
• FIGURE 2 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: DATA TRIANGULATION 41
• FIGURE 3 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: DROC ANALYSIS 42
• FIGURE 4 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS 43
• FIGURE 5 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: COMPANY RESEARCH ANALYSIS 43
• FIGURE 6 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: INTERVIEW DEMOGRAPHICS 44
• FIGURE 7 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: DBMR MARKET POSITION GRID 46
• FIGURE 8 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: SEGMENTATION 51
• FIGURE 9 A RISE IN THE INCIDENCE OF INBORN ERRORS OF METABOLISM AND AN INCREASE IN THE NUMBER OF THE NEWBORN SCREENING PROCEDURES ARE EXPECTED TO DRIVE THE ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET GROWTH IN THE FORECAST PERIOD OF 2023 TO 2030 52
• FIGURE 10 THE AMINO ACID SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET IN 2023 AND 2030 52
• FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET 69
• FIGURE 12 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY PRODUCTS, 2022 82
• FIGURE 13 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY PRODUCTS, 2023-2030 (USD MILLION) 83
• FIGURE 14 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY PRODUCTS, CAGR (2023-2030) 83
• FIGURE 15 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY PRODUCTS, LIFELINE CURVE 84
• FIGURE 16 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY DISEASES, 2022 99
• FIGURE 17 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY DISEASES, 2023-2030 (USD MILLION) 100
• FIGURE 18 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY DISEASES, CAGR (2023-2030) 100
• FIGURE 19 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY DISEASES, LIFELINE CURVE 101
• FIGURE 20 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY AGE GROUP, 2022 116
• FIGURE 21 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY AGE GROUP, 2023-2030 (USD MILLION) 117
• FIGURE 22 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY AGE GROUP, CAGR (2023-2030) 117
• FIGURE 23 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY AGE GROUP, LIFELINE CURVE 118
• FIGURE 24 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY FORMS, 2022 123
• FIGURE 25 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY FORMS, 2023-2030 (USD MILLION) 124
• FIGURE 26 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY FORMS, CAGR (2023-2030) 124
• FIGURE 27 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY FORMS, LIFELINE CURVE 125
• FIGURE 28 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY PACKAGING, 2022 131
• FIGURE 29 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY PACKAGING, 2023-2030 (USD MILLION) 132
• FIGURE 30 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY PACKAGING, CAGR (2023-2030) 132
• FIGURE 31 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY PACKAGING, LIFELINE CURVE 133
• FIGURE 32 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY DISTRIBUTION CHANNEL, 2022 139
• FIGURE 33 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 140
• FIGURE 34 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 140
• FIGURE 35 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 141
• FIGURE 36 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: SNAPSHOT (2022) 148
• FIGURE 37 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY COUNTRY (2022) 149

• FIGURE 38 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY COUNTRY (2023 & 2030) 149
• FIGURE 39 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY COUNTRY (2022 & 2030) 150
• FIGURE 40 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY PRODUCTS (2023-2030) 150
• FIGURE 41 ASIA PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: COMPANY SHARE 2022 (%) 283